Corporate profits have overwhelmingly exceeded low expectations so far this earnings season, but there are still plenty of wild cards left in the deck.
We wanted a permissionless system where users set the rules. We got a new financial toy for a small handful of wealthy companies and individuals.
Learn about how pharmaceutical companies price drugs, why prices are often very high, and why it can be difficult to settle on a suitable price.
Huawei will stop making its flagship Kirin chipsets next month, as the impact of U.S. pressure on the Chinese tech giant grows.Read More